These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7684443)

  • 41. In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Sumiyoshi T; Kido H; Sakamoto H; Urasaki K; Suzuki K; Yamaguchi N; Mori H; Shiba K; Yokogawa K
    Pharmacol Biochem Behav; 1994 Mar; 47(3):553-7. PubMed ID: 7516078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.
    Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
    Neuropharmacology; 1999 Aug; 38(8):1185-94. PubMed ID: 10462131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Leysen JE; Janssen PM; Schotte A; Luyten WH; Megens AA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S40-54. PubMed ID: 7530377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of atypical antipsychotic agents on social behavior in rodents.
    Corbett R; Hartman H; Kerman LL; Woods AT; Strupczewski JT; Helsley GC; Conway PC; Dunn RW
    Pharmacol Biochem Behav; 1993 May; 45(1):9-17. PubMed ID: 7685916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity.
    Mokrosz JL; Chojnacka-Wójcik E; Dereń-Wesołek A; Kłodzińska A; Maćkowiak M; Bielecka Z; Paluchowska MH
    Drug Des Discov; 1994 Apr; 11(3):197-203. PubMed ID: 7548635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
    Reuss B; Unsicker K
    Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone.
    Cohen LJ
    Pharmacotherapy; 1994; 14(3):253-65. PubMed ID: 7524043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
    Matsubara S; Meltzer HY
    Life Sci; 1989; 45(15):1397-406. PubMed ID: 2571912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and atypical antipsychotic profile of some 2-(2-piperidinoethyl)benzocycloalkanones as analogues of butyrophenone.
    Fontenla JA; Osuna J; Rosa E; Castro ME; G-Ferreiro T; Loza-García I; Calleja JM; Sanz F; Rodríguez J; Raviña E
    J Med Chem; 1994 Aug; 37(16):2564-73. PubMed ID: 7914540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
    Nyberg S; Farde L; Eriksson L; Halldin C; Eriksson B
    Psychopharmacology (Berl); 1993; 110(3):265-72. PubMed ID: 7530376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo.
    Sumiyoshi T; Kido H; Sakamoto H; Urasaki K; Suzuki K; Yamaguchi N; Mori H; Shiba K
    Pharmacol Biochem Behav; 1994 Sep; 49(1):165-9. PubMed ID: 7816868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA.
    D'Souza U; McGuffin P; Buckland PR
    Neuropharmacology; 1997; 36(11-12):1689-96. PubMed ID: 9517440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Serotonin antagonism involved in the antipsychotic effect. Confirmation with ritanserine and risperidone].
    Niemegeers CJ; Awouters F; Janssen PA
    Encephale; 1990; 16(2):147-51. PubMed ID: 1693560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.
    Panocka I; Pompei P; Massi M
    Brain Res Bull; 1993; 31(5):595-9. PubMed ID: 7684315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    Hall H; Halldin C; Nyberg S; Farde L; Sedvall G
    Eur Neuropsychopharmacol; 1995 Mar; 5(1):19-25. PubMed ID: 7542051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survey on the pharmacodynamics of the new antipsychotic risperidone.
    Megens AA; Awouters FH; Schotte A; Meert TF; Dugovic C; Niemegeers CJ; Leysen JE
    Psychopharmacology (Berl); 1994 Feb; 114(1):9-23. PubMed ID: 7531353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
    Farde L; Nyberg S; Oxenstierna G; Nakashima Y; Halldin C; Ericsson B
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):19S-23S. PubMed ID: 7537284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.
    Roth BL; Ciaranello RD; Meltzer HY
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1361-5. PubMed ID: 1347569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.